![Morten Albrechtsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Morten Albrechtsen
Vorstandsvorsitzender bei FLUOGUIDE A/S
Vermögen: 7 Mio $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Andreas Kjaer | M | 61 | 6 Jahre | |
Peter Morch Eriksen | M | 64 | 5 Jahre | |
Shomit Ghose | M | 63 | 5 Jahre | |
Mats Johan Peter Thorén | M | 53 | 3 Jahre | |
Sven-Erik Lennart Nilsson | M | 83 |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 23 Jahre |
Micaela Sjökvist | F | 54 | 5 Jahre | |
Peter Torstensen | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 15 Jahre |
Michael Bo Pålsson | M | - |
Appium Partners
| - |
Ole Larsen | M | 59 | 1 Jahre | |
Peter Birk Rasmussen | M | 59 |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 10 Jahre |
Jörgen Axel Thorball | M | 62 |
Retipharma Ivs
![]() Retipharma Ivs Pharmaceuticals: MajorHealth Technology Retipharma Ivs develops drugs for eye disorders. The company is based in Copenhagen, Denmark. | 6 Jahre |
Grethe Nørskov Rasmussen | M | 62 | 5 Jahre | |
Thomas Wiborg Steen | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 10 Jahre |
Ulf Peter Nilsson | M | 54 | 10 Jahre | |
Michael Engsig | M | - | 1 Jahre | |
Claus Strand Kristensen | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 12 Jahre |
David Ventzel | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 12 Jahre |
Jes Nordentoft | M | 46 |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 10 Jahre |
Daniela Morath | F | 44 | 6 Jahre | |
Dorthe Gronnegaard Mejer | F | 49 | 4 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jan Nilsson | M | 75 | 7 Jahre | |
Arne Ferstad | M | 74 | 2 Jahre | |
Bengt Arvid Westrin | M | 66 | - | |
Susana Ayesa Alvarez | M | 54 | - | |
Martin Ettrup | M | - |
Wear&Care ApS
![]() Wear&Care ApS Services to the Health IndustryHealth Services Wear&Care ApS develops and implements welfare technological solutions. It specializes in overcome of diseases which include dementia, sclerosis, parkinson, brain damage, cerebral paralysis, spinal diseases, and various physical handicaps. The company was founded by Martin Ettrup Hansen and Helle Thambo Andersen in 2012 and is headquartered in Odense, Denmark. | - |
Helle Thambo | M | - |
Wear&Care ApS
![]() Wear&Care ApS Services to the Health IndustryHealth Services Wear&Care ApS develops and implements welfare technological solutions. It specializes in overcome of diseases which include dementia, sclerosis, parkinson, brain damage, cerebral paralysis, spinal diseases, and various physical handicaps. The company was founded by Martin Ettrup Hansen and Helle Thambo Andersen in 2012 and is headquartered in Odense, Denmark. | - |
Elisabeth Marianne Bock | F | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
Lars Christian Rønn | M | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
Vladyslav Soroka | M | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
Arne Valdemar Holm | M | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
Flemming Martin Poulsen | M | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
Marianne Olsen | F | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
Volodymyr Berezin | M | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 9 Jahre |
Karin Agerman | M | 51 | 6 Jahre | |
Søren Jonas Bruun | M | 63 |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 2 Jahre |
Morten Heide | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 9 Jahre |
Per Lennart Ericsson | M | 59 | - | |
Henrik Hang | M | 42 | 1 Jahre | |
Stephen Rees | M | - |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
Niels Henrik Olsen | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | - |
Søren Wilsbech Lottrup | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 10 Jahre |
Hilde Furberg | F | 65 | - | |
Peter Holme Jensen | M | 54 |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 8 Jahre |
Jesper Knudsen | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 6 Jahre |
Morten Mølgaard Jensen | M | - |
Accelerace Management A/S
![]() Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | 7 Jahre |
Jan-Eric Österlund | M | 79 |
ENKAM Pharmaceuticals A/S
![]() ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 15 Jahre |
Henrik Kristian Moltke | M | 66 | 2 Jahre | |
Anna Jönsson | F | 40 | 1 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Dänemark | 39 | 81,25% |
Schweden | 10 | 20,83% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Morten Albrechtsen
- Persönliches Netzwerk